Author

N. Sullivan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Assay:cryo-EM· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Organism:human· 1

Frequent Co-Authors

J. R. Mascola· 3 shared B. Zhang· 2 shared I.-T. Teng· 2 shared J. Misasi· 2 shared M. Choe· 2 shared P. D. Kwong· 2 shared T. Liu· 2 shared T. Zhou· 2 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

J. R. Mascola

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron

I.-T. Teng, A. F. Nazzari, M. Choe, T. Liu, M. Oliveira de Souza, Y. Petrova, Y. Tsybovsky, S. Wang, B. Zhang, M. Artamonov, B. Madan, A. Huang, S. N. Lopez Acevedo, X. Pan, T. J. Ruckwardt, , P. D. Kwong

The paper designs and produces molecular probes for SARS-CoV-2 variants to assess immune responses and isolate neutralizing antibodies.

bioRxiv · Dec 29, 2021 · PreprintImmunology

Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529

T. Zhou, L. Wang, J. Misasi, A. Pegu, Y. Zhang, D. R. Harris, A. S. Olia, C. A. Talana, E. S. Yang, M. Chen, M. Choe, W. Shi, I.-T. Teng, A. Creanga, C. Jenkins, , P. D. Kwong

The paper identifies potent monoclonal antibodies that neutralize the B.1.1.529 SARS-CoV-2 variant and reveals structural mechanisms enabling their effectiveness.

bioRxiv · Dec 27, 2021Immunology

Activation of bone marrow adaptive immunity in type 2 diabetes: rescue by co-stimulation modulator Abatacept

m. Santopaolo, N. Sullivan, A. Thomas, V. V. Alvino, L. Nicholson, Y. Gu, G. Spinetti, M. Kallikourdis, A. Blom, P. Madedddu

This paper investigates adaptive immune activation in bone marrow of T2D patients and mice, showing that Abatacept reduces T cell activation and improves cardiac function.

bioRxiv · Jul 3, 2020Immunology

Extensive CD8β depletion does not prevent control of viral replication or protection from challenge in macaques chronically infected with a live attenuated simian immunodeficiency virus

M. S. Sutton, A. Ellis-Connell, A. J. Balgeman, G. L. Barry, A. M. Weiler, S. J. Hetzel, Y. Zhou, A. Kilby, R. Mason, K. K. Biris, J. R. Mascola, N. Sullivan, M. Roederer, T. C. Friedrich, S. L. O'Connor

This study shows that CD8β+ T cell depletion in SIV-infected macaques does not prevent viral control or protection from challenge, suggesting CD8β+ T cells are not essential for these outcomes.

bioRxiv · Apr 13, 2019Immunology